Waters JD, Sanchez C, Sahin A, Futalan D, Gonda DD, Scheer JK, Akers J, Palanichamy K, Waterman P, Chakravarti A, Weissleder R, Morse B, Marsh N, Furfine E, Chen CC, Carvajal I, Carter BSCT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.J Neurooncol 110(1) 37-48 10/1/2012
Estrada-Bernal A, Palanichamy K, Ray Chaudhury A, Van Brocklyn JRInduction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.Neuro Oncol 14(4) 405-15 4/1/2012
Palanichamy K, Sreejayan N, Ontko ACOvercoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.J Inorg Biochem 106(1) 32-42 1/1/2012
Kim TH, Song J, Alcantara Llaguno SR, Murnan E, Liyanarachchi S, Palanichamy K, Yi JY, Viapiano MS, Nakano I, Yoon SO, Wu H, Parada LF, Kwon CSuppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth.PLoS One 7(8) e42818 1/1/2012